OptimizeRx OPRX
Last Price
52 Week Range
$3.99 - $22.25
Next Earnings Date
Mar 11 2026 (Estimate)
Next Earnings Date
Mar 11 2026 (Est.)
Last Price
OPRX Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
OptimizeRx Corporation | 10-Q | November 7, 2025 | |
OptimizeRx Corporation | 8-K | November 6, 2025 | |
OptimizeRx Corporation | 8-K | August 19, 2025 | |
OptimizeRx Corporation | 10-Q | August 8, 2025 | |
OptimizeRx Corporation | 8-K | August 7, 2025 | |
OptimizeRx Corporation | 8-K | June 24, 2025 | |
OptimizeRx Corporation | 8-K | June 16, 2025 | |
OptimizeRx Corporation | 10-Q | May 13, 2025 | |
OptimizeRx Corporation | 8-K | May 12, 2025 | |
OptimizeRx Corporation | ARS | April 30, 2025 | |
OptimizeRx Corporation | DEF 14A | April 30, 2025 | |
OptimizeRx Corporation | 8-K | April 18, 2025 | |
OptimizeRx Corporation | 10-K | March 20, 2025 | |
OptimizeRx Corporation | 8-K | March 12, 2025 | |
OptimizeRx Corporation | DEFA14A | March 11, 2025 | |
OptimizeRx Corporation | 8-K | March 10, 2025 | |
OptimizeRx Corporation | 8-K | January 10, 2025 | |
OptimizeRx Corporation | 8-K | December 23, 2024 | |
OptimizeRx Corporation | 10-Q | November 14, 2024 | |
OptimizeRx Corporation | 8-K | November 13, 2024 | |
OptimizeRx Corporation | 10-Q | August 15, 2024 | |
OptimizeRx Corporation | 8-K | August 8, 2024 | |
OptimizeRx Corporation | 8-K | June 7, 2024 | |
OptimizeRx Corporation | 10-Q | May 15, 2024 | |
OptimizeRx Corporation | 8-K | May 14, 2024 | |
OptimizeRx Corporation | ARS | April 29, 2024 | |
OptimizeRx Corporation | DEF 14A | April 29, 2024 | |
OptimizeRx Corporation | 8-K | April 29, 2024 | |
OptimizeRx Corporation | 8-K | April 18, 2024 | |
OptimizeRx Corporation | 10-K | April 15, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.